137 related articles for article (PubMed ID: 31933944)
1. Increased expression of O-GlcNAc transferase (OGT) is a biomarker for poor prognosis and allows tumorigenesis and invasion in colon cancer.
Xu D; Wang W; Bian T; Yang W; Shao M; Yang H
Int J Clin Exp Pathol; 2019; 12(4):1305-1314. PubMed ID: 31933944
[TBL] [Abstract][Full Text] [Related]
2. Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines.
Steenackers A; Olivier-Van Stichelen S; Baldini SF; Dehennaut V; Toillon RA; Le Bourhis X; El Yazidi-Belkoura I; Lefebvre T
Front Endocrinol (Lausanne); 2016; 7():46. PubMed ID: 27252680
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAcase Expression is Sensitive to Changes in O-GlcNAc Homeostasis.
Zhang Z; Tan EP; VandenHull NJ; Peterson KR; Slawson C
Front Endocrinol (Lausanne); 2014; 5():206. PubMed ID: 25520704
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.
Mi W; Gu Y; Han C; Liu H; Fan Q; Zhang X; Cong Q; Yu W
Biochim Biophys Acta; 2011 Apr; 1812(4):514-9. PubMed ID: 21255644
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway.
Zhang P; Wang C; Ma T; You S
Onco Targets Ther; 2015; 8():3305-13. PubMed ID: 26635480
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAcylation promotes malignant phenotypes of bladder cancer cells.
Jin L; Lu MH; Dai GC; Yao Q; Xiang H; Wang LX; Xue BX; Liu X
Neoplasma; 2020 Jul; 67(4):880-888. PubMed ID: 32305058
[TBL] [Abstract][Full Text] [Related]
7. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
[TBL] [Abstract][Full Text] [Related]
8. High
Lin YC; Lin CH; Yeh YC; Ho HL; Wu YC; Chen MY; Chou TY
Oncotarget; 2018 Jul; 9(57):31032-31044. PubMed ID: 30123425
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of O-GlcNAc-transferase associates with aggressiveness of mass-forming cholangiocarcinoma.
Phoomak C; Silsirivanit A; Wongkham C; Sripa B; Puapairoj A; Wongkham S
Asian Pac J Cancer Prev; 2012; 13 Suppl():101-5. PubMed ID: 23480751
[TBL] [Abstract][Full Text] [Related]
10. A Conserved Splicing Silencer Dynamically Regulates O-GlcNAc Transferase Intron Retention and O-GlcNAc Homeostasis.
Park SK; Zhou X; Pendleton KE; Hunter OV; Kohler JJ; O'Donnell KA; Conrad NK
Cell Rep; 2017 Aug; 20(5):1088-1099. PubMed ID: 28768194
[TBL] [Abstract][Full Text] [Related]
11. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
12. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
[TBL] [Abstract][Full Text] [Related]
13. O-linked N-acetylglucosamine transferase enhances secretory clusterin expression via liver X receptors and sterol response element binding protein regulation in cervical cancer.
Kim MJ; Choi MY; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Kim YS; Choi WS
Oncotarget; 2018 Jan; 9(4):4625-4636. PubMed ID: 29435130
[TBL] [Abstract][Full Text] [Related]
14. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAcylation affects β-catenin and E-cadherin expression, cell motility and tumorigenicity of colorectal cancer.
Harosh-Davidovich SB; Khalaila I
Exp Cell Res; 2018 Mar; 364(1):42-49. PubMed ID: 29391154
[TBL] [Abstract][Full Text] [Related]
16. Yeast cells as an assay system for in vivo O-GlcNAc modification.
Nakanishi H; Li F; Han B; Arai S; Gao XD
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870
[TBL] [Abstract][Full Text] [Related]
17. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
18. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
19. O-linked N-acetylglucosamine transferase promotes cervical cancer tumorigenesis through human papillomaviruses E6 and E7 oncogenes.
Kim M; Kim YS; Kim H; Kang MY; Park J; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Park JK; Cho JW; Shin JK; Choi WS
Oncotarget; 2016 Jul; 7(28):44596-44607. PubMed ID: 27331873
[TBL] [Abstract][Full Text] [Related]
20. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
Zhang N; Chen X
Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
